Create: 2013-07-08
Cefuroxime is a 3- (carbamoyloxymethyl)cephalosporin compound having a 7- (2Z)-2- (furan-2-yl)-2- (methoxyimino)acetamido side chain
Cefuroxime 's effect is dependent on its binding to penicillin-binding proteins (PBPs) located in the bacterial cytoplasmic membrane
PubChem Compound 5479529 PubChem Substance 46506681 [6] Acute bacterial maxillary sinusitis: Cefuroxime is effective for treating mild-to-moderate acute bacterial maxillary sinusitis in adult and pediatric patients aged 13 or older due to susceptible strains of H influenzae (non-β-lactamase-producing strains only) or S pneumonia
Cefuroxime axetil is the acetoxyethyl ester of cefuroxime
- 2 of 3 defined stereocentres
Available for iPhone, iPad, Android, and Web
Sigma-Aldrich
Its beta-lactamase stability makes it useful in treating a variety of Cefuroxime is used to treat a wide variety of bacterial infections
Cefuroxime
5 Because of the advantages of using a suspension and high bioavailability in cefuroxime axetil Ceftin Used for Skin Infection, Ear Infection, Urinary Tract Infection, Bacterial Infection, Upper Respiratory Infection, Lower Respiratory Infection, Sinus Infection, Lyme Disease Cefuroxime is an antibiotic that can be used to treat many types of bacterial infections throughout your body
Cefuroxime Axetil
Cefuroxime axetil is an oral cephalosporin which is rapidly hydrolysed to the active parent compound, cefuroxime
14) Dates
Cefuroxime's effect is dependent on its binding to penicillin-binding proteins enwiki Cefuroxime axetil; fawiki سفوروکسیم اکستیل; itwiki Acetossietilcefuroxima; jawiki セフロキシム・アキセチル; shwiki Cefuroksim aksetil; siwiki Cefuroxime axetil; srwiki Cefuroksim aksetil; zhwiki 头孢呋辛酯 USP drug classification [BR: br08302] Antibacterials
613 Acting mainly on gram-positive and gram-negative bacteria
Cefuroxime Sodium is the sodium salt form of cefuroxime and a semi-synthetic, broad-spectrum, beta-lactamase resistant, second-generation cephalosporin antibiotic with bactericidal activity
doi: 10
NDC 54868-5022-2
Cefuroxime Axetil-d3 | C20H22N4O10S | CID 71314629 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological PubChem Substance ID: 329749260
USP
To reduce the development of drug-resistant bacteria and maintain the effectiveness of cefuroxime axetil and other antibacterial drugs, cefuroxime axetil should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria
Embracing the classification of a second-generation cephalosporin, CA exhibits a broad spectrum of activity, effectively targeting both Gram-positive and Gram-negative bacteria
1 of 10
It is mainly effective against Streptococci, beta-lactamase-producing bacteria, and gram-negative aerobes
- 2 of 2 defined stereocentres
CEFTIN Tablets are film-coated and contain the equivalent of 125, 250, or 500 mg of cefuroxime as cefuroxime axetil
Milk samples were taken from each breast 30 Cefuroxime axetil is in the amorphous form and has the following structural formula: Tablets are film-coated and contain the equivalent of 250 mg or 500 mg of cefuroxime as cefuroxime axetil USP
These include pneumonia, meningitis, otitis media, sepsis, urinary tract infections, and Lyme disease
2)]
Recommended Products
PubChem Substance ID: 329774816
Cefuroxime axetil offers an in vitro More common side effects
1 of 10
13 years or older: Tablets: 250 or 500 mg orally every 12 hours
GlaxoSmithKline bán loại kháng sinh này ở Anh, Úc, Thổ Nhĩ Kỳ CEFTIN tablets, 500 mg of cefuroxime (as cefuroxime axetil), are white, capsule-shaped, film-coated tablets engraved with "GX EG2" on one side and blank on the other side as follows: 20 Tablets/Bottle NDC 0173-0394-00
Cefuroxime axetil offers an in vitro antibacterial spectrum against many gram-positive and some gram-negative organisms
The Committee's evaluation noted the large percentage of unidentified compounds in the total radiolabelled cefuroxime residue in milk, representing >80% of the total, thus justifying the need for a more complete identification of these residues
USES: Cefuroxime is used to treat a wide variety of bacterial infections
1 of 10
Cefepime is active against Gram-positive and Gram-negative bacteria, and has greater activity against both compared to third-generation antibiotics
It is a 3- (carbamoyloxymethyl)cephalosporin, a
Average mass 510
Since cefuroxime is not absorbed orally, the 1-acetyloxyethyl (axetil)
This medication is
cefuroxime axetil Ceftin Used for Skin Infection, Ear Infection, Urinary
Search PubChem
0)oct-2-ene-2-carboxylic acid Computed by PubChem 2
Computed by PubChem 2
This medication can cause side effects like stomach upset
Cefuroxime axetil is in the amorphous form and has the following structural formula: Tablets are film-coated and contain the equivalent of 250 mg or 500 mg of cefuroxime as cefuroxime axetil USP
1988 Aug;22(2):101-4
Author A M Emmerson 1 Affiliation 1 Department of Microbiology and Immunobiology, Queen's University of Belfast, Northern Ireland
Recommended Products
The antibacterial activity of cefuroxime in Cefuroxime axetil is a orally active prodrug formulation of cefuroxime, which upon absorption undergoes immediate deesterification to free cefuroxime
1 Important Administration Instructions
Cefuroxime is subsequently distributed throughout the extracellular fluids
Cefuroxime Axetil E-isomers, United States Pharmacopeia (USP) Reference Standard
≥40 kg: Same as adult dose
068878 Da
To reduce the development of drug-resistant bacteria and maintain the effectiveness of cefuroxime axetil and other antibacterial drugs, cefuroxime axetil should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria
9462439
Adult: 750 mg 8 hourly via deep IM inj or IV inj over 3-5 minutes or infused over 30-60 minutes
The 58th Committee meeting established a temporary ADI for cefuroxime of 0–30mg/kg bw on the basis of the MIC50 for Bifidobacterium spp
[4] One mother received cefuroxime axetil 500 mg orally three times daily for acute mastitis of the left breast following incision and drainage of the lesion
PubChem Substance ID: 329774816